Central Pharmaceuticals Ltd. (DSE:CENTRALPHL)

Central Pharmaceuticals Revenue

Central Pharmaceuticals had revenue of 8.48M BDT in the quarter ending September 30, 2024, a decrease of -72.70%. This brings the company's revenue in the last twelve months to 7.02M, down -87.04% year-over-year. In the fiscal year ending June 30, 2024, Central Pharmaceuticals had annual revenue of 29.60M with 0.93% growth.

• Revenue (ttm): 7.02M
• Revenue Growth: -87.04%
• P/S Ratio: 145.08
• Revenue / Employee: 94.85K
• Employees: 74
• Market Cap: 1.02B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2024	29.60M	271.46K	0.93%
Jun 30, 2023	29.33M	3.33M	12.81%
Jun 30, 2022	26.00M	-122.15M	-82.45%
Jun 30, 2021	148.15M	8.06M	5.75%
Jun 30, 2020	140.09M	-167.37M	-54.44%